Cargando…

Endoscopic dacryocystorhinostomy to treat congenital nasolacrimal canal dysplasia: a retrospective analysis in 40 children

BACKGROUND: To investigate the therapeutic effectiveness and safety of endoscopic dacryocystorhinostomy (EN-DCR) to treat congenital nasolacrimal canal dysplasia (CNCD). METHODS: Forty children (50 eyes) with congenital nasolacrimal duct obstruction (CNLDO) and lacrimal bony dysplasia, including 8 c...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Yan-Hui, Zhang, Cheng-Yue, Liu, Wen, Wu, Qian, Yu, Gang, Li, Li, Wei, Wen-Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889731/
https://www.ncbi.nlm.nih.gov/pubmed/31796021
http://dx.doi.org/10.1186/s12886-019-1256-1
_version_ 1783475482448101376
author Cui, Yan-Hui
Zhang, Cheng-Yue
Liu, Wen
Wu, Qian
Yu, Gang
Li, Li
Wei, Wen-Bin
author_facet Cui, Yan-Hui
Zhang, Cheng-Yue
Liu, Wen
Wu, Qian
Yu, Gang
Li, Li
Wei, Wen-Bin
author_sort Cui, Yan-Hui
collection PubMed
description BACKGROUND: To investigate the therapeutic effectiveness and safety of endoscopic dacryocystorhinostomy (EN-DCR) to treat congenital nasolacrimal canal dysplasia (CNCD). METHODS: Forty children (50 eyes) with congenital nasolacrimal duct obstruction (CNLDO) and lacrimal bony dysplasia, including 8 children with bony atresia (10 eyes) and 32 with bony stenosis (40 eyes), were recruited in this retrospective study. Standardized EN-DCR was performed in all cases. The postoperative observations included relief of symptoms, fluorescein dye disappearance test (FDDT), syringing of lacrimal passages and anastomotic patency under nasal endoscopy. Patients were followed up for 8–18 months. RESULTS: Standardized EN-DCR surgery had a success (cure and improvement) rate of 100%, including a cure rate of 82% and an improvement rate of 18%. The cure rate among 40 cases of bony nasolacrimal duct stenosis was 82.5%, while that of 10 cases of bony nasolacrimal duct atresia was 80%. Statistical analysis showed that nether the receipt of other treatments before surgery nor the type of bony nasolacrimal duct dysplasia affected the cure rate. No significant complications were observed during postoperative follow-up except for four cases (4 eyes) that suffered middle turbinate and nasal mucosal adhesion and two cases with sinusitis. CONCLUSIONS: CNCD is a type of CNLDO that does not respond to conservative and conventional treatment. EN-DCR represents a safe and effective treatment for children with CNCD. In addition, the combination of EN-DCR with lacrimal CT scanning provides advantages over traditional lacrimal surgery in that it has a high success rate with a low incidence of complications.
format Online
Article
Text
id pubmed-6889731
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68897312019-12-11 Endoscopic dacryocystorhinostomy to treat congenital nasolacrimal canal dysplasia: a retrospective analysis in 40 children Cui, Yan-Hui Zhang, Cheng-Yue Liu, Wen Wu, Qian Yu, Gang Li, Li Wei, Wen-Bin BMC Ophthalmol Research Article BACKGROUND: To investigate the therapeutic effectiveness and safety of endoscopic dacryocystorhinostomy (EN-DCR) to treat congenital nasolacrimal canal dysplasia (CNCD). METHODS: Forty children (50 eyes) with congenital nasolacrimal duct obstruction (CNLDO) and lacrimal bony dysplasia, including 8 children with bony atresia (10 eyes) and 32 with bony stenosis (40 eyes), were recruited in this retrospective study. Standardized EN-DCR was performed in all cases. The postoperative observations included relief of symptoms, fluorescein dye disappearance test (FDDT), syringing of lacrimal passages and anastomotic patency under nasal endoscopy. Patients were followed up for 8–18 months. RESULTS: Standardized EN-DCR surgery had a success (cure and improvement) rate of 100%, including a cure rate of 82% and an improvement rate of 18%. The cure rate among 40 cases of bony nasolacrimal duct stenosis was 82.5%, while that of 10 cases of bony nasolacrimal duct atresia was 80%. Statistical analysis showed that nether the receipt of other treatments before surgery nor the type of bony nasolacrimal duct dysplasia affected the cure rate. No significant complications were observed during postoperative follow-up except for four cases (4 eyes) that suffered middle turbinate and nasal mucosal adhesion and two cases with sinusitis. CONCLUSIONS: CNCD is a type of CNLDO that does not respond to conservative and conventional treatment. EN-DCR represents a safe and effective treatment for children with CNCD. In addition, the combination of EN-DCR with lacrimal CT scanning provides advantages over traditional lacrimal surgery in that it has a high success rate with a low incidence of complications. BioMed Central 2019-12-03 /pmc/articles/PMC6889731/ /pubmed/31796021 http://dx.doi.org/10.1186/s12886-019-1256-1 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Cui, Yan-Hui
Zhang, Cheng-Yue
Liu, Wen
Wu, Qian
Yu, Gang
Li, Li
Wei, Wen-Bin
Endoscopic dacryocystorhinostomy to treat congenital nasolacrimal canal dysplasia: a retrospective analysis in 40 children
title Endoscopic dacryocystorhinostomy to treat congenital nasolacrimal canal dysplasia: a retrospective analysis in 40 children
title_full Endoscopic dacryocystorhinostomy to treat congenital nasolacrimal canal dysplasia: a retrospective analysis in 40 children
title_fullStr Endoscopic dacryocystorhinostomy to treat congenital nasolacrimal canal dysplasia: a retrospective analysis in 40 children
title_full_unstemmed Endoscopic dacryocystorhinostomy to treat congenital nasolacrimal canal dysplasia: a retrospective analysis in 40 children
title_short Endoscopic dacryocystorhinostomy to treat congenital nasolacrimal canal dysplasia: a retrospective analysis in 40 children
title_sort endoscopic dacryocystorhinostomy to treat congenital nasolacrimal canal dysplasia: a retrospective analysis in 40 children
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889731/
https://www.ncbi.nlm.nih.gov/pubmed/31796021
http://dx.doi.org/10.1186/s12886-019-1256-1
work_keys_str_mv AT cuiyanhui endoscopicdacryocystorhinostomytotreatcongenitalnasolacrimalcanaldysplasiaaretrospectiveanalysisin40children
AT zhangchengyue endoscopicdacryocystorhinostomytotreatcongenitalnasolacrimalcanaldysplasiaaretrospectiveanalysisin40children
AT liuwen endoscopicdacryocystorhinostomytotreatcongenitalnasolacrimalcanaldysplasiaaretrospectiveanalysisin40children
AT wuqian endoscopicdacryocystorhinostomytotreatcongenitalnasolacrimalcanaldysplasiaaretrospectiveanalysisin40children
AT yugang endoscopicdacryocystorhinostomytotreatcongenitalnasolacrimalcanaldysplasiaaretrospectiveanalysisin40children
AT lili endoscopicdacryocystorhinostomytotreatcongenitalnasolacrimalcanaldysplasiaaretrospectiveanalysisin40children
AT weiwenbin endoscopicdacryocystorhinostomytotreatcongenitalnasolacrimalcanaldysplasiaaretrospectiveanalysisin40children